The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for ...
FOR countless people across Ireland, the simple act of laughing, coughing, or rushing for the bus comes with a hidden worry.
The tire curing bladder release agent market is poised for remarkable growth over the next decade, forecast to climb from USD ...
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
FDA prioritizes review of enfortumab vedotin and pembrolizumab for muscle-invasive bladder cancer, showing promising results in reducing recurrence and mortality.
EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.
The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...
The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...
(MENAFN- The Conversation) The bladder is easy to overlook – until it starts causing trouble. This small, balloon-like organ in the lower urinary tract quietly stores and releases urine, helping the ...
Just like your heart or lungs, your bladder needs care - neglect it and you risk a string of health problems that can even ...